The organoid: A research model for ovarian cancer
Epithelial ovarian cancer (EOC) is a heterogeneous disease with a variety of distinct clinical and molecular characteristics. The currently available and common research models for EOC include tumor cell lines and patient-derived xenografts. However, these models have certain shortcomings: establish...
Main Authors: | Yu-Hsun Chang, Kun-Chi Wu, Tomor Harnod, Dah-Ching Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Tzu-Chi Medical Journal |
Subjects: | |
Online Access: | http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2022;volume=34;issue=3;spage=255;epage=260;aulast= |
Similar Items
-
Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
by: Ergang Wang, et al.
Published: (2022-12-01) -
Patient-Derived Organoids of Cholangiocarcinoma
by: Christopher Fabian Maier, et al.
Published: (2021-08-01) -
Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma
by: XiaoChang Fang, et al.
Published: (2024-01-01) -
Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
by: Wai Sun Chan, et al.
Published: (2023-10-01) -
Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
by: Christian Moya Gamboa, et al.
Published: (2021-03-01)